Patient Cohorts and Treatment
nonmetastatic esophageal cancer
SECONDARY
This unplanned, post hoc secondary analysis included evaluable patients with nonmetastatic esophageal cancer who underwent definitive CRT in the RTOG 8501, RTOG 9405 (